However, the fact that AR and GR have opposite functions in the presence and absence of ER highlights the importance of characterising the functional interplay between different steroid hormone receptor signalling pathways in both luminal and nonluminal breast cancer subtypes, to fully exploit their therapeutic potential. The gene discussed is NR3C1; the disease is breast carcinoma.